Belite Bio, Inc (BLTE)

USD 62.96

(-0.16%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020
Revenue - - - -
Cost of Revenue 399 Thousand 198 Thousand 30 Thousand 17 Thousand
Gross Profit -399 Thousand -198 Thousand -30 Thousand -17 Thousand
Operating Expenses 31.66 Million 12.82 Million 9.79 Million 5.74 Million
Selling, General and Administrative Expenses 6.82 Million 3.95 Million 2.37 Million 2.05 Million
Research and Development Expenses 24.84 Million 8.86 Million 7.41 Million 3.68 Million
Other Expenses - 166 Thousand 126 Thousand -
Cost and Expenses 31.66 Million 12.82 Million 9.79 Million 5.74 Million
Operating Income -31.66 Million -12.82 Million -9.79 Million -5.74 Million
Interest Expense 25 Thousand 16 Thousand - 21 Thousand
Income Tax Expense 9000.00 -173 Thousand 126 Thousand 1000.00
Earnings before Tax -31.62 Million -12.64 Million -9.66 Million -5.75 Million
Net Income -31.63 Million -12.47 Million -9.79 Million -5.75 Million
Earnings Per Share Basic -1.19 -0.62 -0.41 -0.24
Earnings Per Share Diluted -1.19 -0.62 -0.41 -0.24
Weighted Average Shares Outstanding 26.59 Million 19.97 Million 24.09 Million 24.09 Million
Weighted Average Shares Outstanding (Diluted) 26.59 Million 19.97 Million 24.09 Million 24.09 Million
Gross Margin - - - -
EBIT Margin - - - -
Profit Margin - - - -
EBITDA -31.52 Million -12.43 Million -9.63 Million -5.71 Million
Earnings Before Tax Margin - - - -

Income Statement Charts